Delivery Order SPE2DB22D3019-SPE2DB25FK3JN
Award Date
3/28/25
Potential Completion Date
3/31/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bromfenac Sodium 0.09% eye drops, a prescription medication. The contract has a ceiling value of $1,303.05 and runs through February 6, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bromfenac Sodium 0.09% eye drops, a pharmaceutical product, with a ceiling value of $2,695.47 and a period of performance ending on November 15, 2024. The contract is not designated as a set-aside and represents an individual delivery order issued under a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $3,448.90 firm fixed-price contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a prescription medication used to treat eye inflammation and pain. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This $38,872.30 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,562,911,110 units of Bromfenac Sodium 0.09% Eye Drops, 1.7 ml, to be delivered by November 28, 2023. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The award is for the provision of Bromfenac Sodium 0.09% Eye Drops in 1.7ml containers, with a total ceiling value of $1,131.37 and a period of performance through March 12, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to...
This $5,687.78 delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the procurement of Bromfenac Sodium 0.09% eye drops. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. This award is associated with a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply Bromfenac Sodium 0.09% Eye Drops 1.7 mL. The contract has a firm-fixed price and a ceiling value of $1,860.93. It was awarded on August 7, 2024, with an ultimate completion date of August 8, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Bromfenac Sodium 0.09% eye drops. This $1,488.72 contract has a performance period through March 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award, valued at $2,720.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a prescription ophthalmic medication, with a completion date of May 17, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Bromfenac Sodium 0.07% Eye Drops, 3mL. The contract has a ceiling value of $1,059.39 and a completion date of August 1, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty...